Dose Intensity and the Importance of Febrile Neutropenia Prevention

Has Axillary Clearance Become Obsolete?

Immune Check-point Blockade for Breast Cancer

Immune Approaches to the Treatment of Breast Cancer, around the Corner?

Immune Monitoring for Immuno-oncology Clinical Trials

SUBGROUP ANALYSIS OF ASIAN POPULATION AMONG PALOMA-2 TRIALS

FIRST-LINE RIBOCICLIB + LETROZOLE IN POSTMENOPAUSAL ASIAN WOMEN WITH HORMONE RECEPTOR-POSITIVE (HR+), HER2-NEGATIVE (HER2-) ADVANCED BREAST CANCER (ABC): A SUBGROUP ANALYSIS OF MONALEESA-2

BREAST MRI MONITORING FOR YOUNG BREAST CANCER PATIENTS AFTER BREAST CONSERVATION THERAPY: A MULTICENTER PROSPECTIVE STUDY

A PROSPECTIVE, RANDOMIZED, MULTICENTER, OPEN-LABEL PHASE III NEOADJUVANT STUDY TO COMPARE CHEMOTHERAPY WITH ENDOCRINE THERAPY IN PREMENOPAUSAL PATIENTS WITH HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE BREAST CANCER

Fertility Preservation

Chemotherapy - Endocrine Therapy Sequence in Premenopausal Patients

Long-term Toxicity of Endocrine Therapy

Overcoming Heterogeneity: Single Cell Sequencing of Breast Cancer

Practical Implications of Next Generation Sequencing in Breast Cancer: Promises and Challenges

Molecular Heterogeneity of Triple-negative Breast Cancer

Recent Insight into Clinic for HER2+ mBC Patients

Immuno-oncology of Breast Cancer

Survivorship Issues of the Metastatic, Recurrent and Intractable Breast Cancer

Nursing Care in Bone Metastasis

Nursing Care in Visceral Metastasis

Specialist Nursing Roles for the Patient with Metastatic, Recurrent and Intractable Breast Cancer

Complementary and Alternative Therapies

Breast Cancer Genetics - How Is It Changing Our Practice

Panel Testing and SNP Testing (Polygenic Risk Score) in Asian Women

Breast Cancer Genetics and Cancer Policy

Genetic Susceptibility to Breast Cancer: Roles of High-moderate and Modest-penetrance Alleles

Clinical Considerations for the Development of Biosimilars in Oncology

G-CSF (PEG-GCSF) Biosimilar: Clinical Application and Experience

Trastuzumab Biosimilar

Do We Need Excision in cCR Patients after Neoadjuvant Chemotherapy

Can We Omit Sentinel Lymph Node Biopsy in Some Patients

Extent and Role of Radiation Therapy in pCR Patients

USG or FNA for Predicting Node Positive in Breast Cancer

Accuracy of PET for Lymph Node Evaluation

Nomogram to Predict 3 or More Lymph Node Metastasis

ABCN Collaborative Group

ABCN Mentorship

Wisdom Sharing: Foundation, Establishment, and Development of BIG

Clinical Trail Collaboration across and beyond Asia-Pacific - Korea

Clinical Trail Collaboration across and beyond Asia-Pacific - Hong Kong

Clinical Trail Collaboration across and beyond Asia-Pacific - Japan

Clinical Trail Collaboration across and beyond Asia-Pacific - Singapore

Prognostic Diagnosis for HR+/HER2- Early Breast Cancer Patient Based on the Algorithm through the Gene Expression Signature